arrow
M

Maria Fusaro

Institute of Clinical Physiology
H指数:34
被引数:4,455

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vitamin D in coronary heart disease: a Mendelian randomization meta-analysis of data stratified by 25(OH)D levels

维生素D在冠状动脉心脏病中的作用:一项按25(OH)D水平分层的孟德尔随机化Meta分析

2026-09-220
PRE
Estimating the Extent of Missed Opportunities for Osteoporosis Treatment Before Hip Fracture Occurrence

估计股骨颈骨折发生前骨质疏松症治疗缺失机会的范围

2026-08-290
OAAI
Prevalence, predictors, and clinical impact of vitamin D deficiency on 12-month outcomes in hip fracture patients

维生素D缺乏在髋部骨折患者12个月预后中的患病率、预测因子及临床影响

2026-06-270
OAAI
Bone turnover markers in the management of CKD-associated osteoporosis-a European consensus

慢性肾病相关性骨质疏松管理中的骨转换标志物——欧洲共识

2026-04-011
PREAI
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis

双凹椎体骨折作为惰性系统性肥大细胞增多症与原发性骨质疏松症相比的一个可能的特征性表现

2025-12-100
OAAI
Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working Group

钙化防御的诊断、管理及未来方向:欧洲肾脏协会CKD-MBD工作组代拟的综合更新

2025-12-010
OAAI
A consensus statement on the management of vertebral fractures in CKD stages G4–G5D

关于CKD G4–G5D阶段椎体骨折管理的共识声明

2025-11-280
OAAI
Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists

来自意大利肾脏病学家关于CKD相关性骨质疏松管理的全国性调查的真实世界数据

2025-07-160
PRE
Bone histomorphometry for the diagnosis of renal osteodystrophy – a European consensus statement

骨组织形态计量学在肾性骨病诊断中的应用——欧洲共识声明

Bone
IF3.6
2025-05-280
OA
Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort

成人X-连锁低磷酸盐血症患者对burosumab治疗反应的预测因子:来自意大利队列的真实世界数据

2025-05-050
OA
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

骨转换标志物在骨质疏松症诊断和管理中的作用的更新: 欧洲骨质疏松症,骨关节炎和肌肉骨骼疾病临床和经济方面学会 (ESCEO),国际骨质疏松症基金会 (IOF) 和国际临床化学和实验室医学联合会 (IFCC) 的共识论文

2025-03-281
OA
Possible role of bone turnover markers in the diagnosis of adult hypophosphatasia

骨转换标志物在成人低磷酸酯酶症诊断中的可能作用

2024-11-050
PRE
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study
2024-10-020
OAAI
Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices
2023-11-297
OAAI
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes
2023-11-234
OA